EE200000357A - Meetod 16ß-arüüloksü-4-asasteroidide valmistamiseks ning vaheühendid - Google Patents

Meetod 16ß-arüüloksü-4-asasteroidide valmistamiseks ning vaheühendid

Info

Publication number
EE200000357A
EE200000357A EEP200000357A EEP200000357A EE200000357A EE 200000357 A EE200000357 A EE 200000357A EE P200000357 A EEP200000357 A EE P200000357A EE P200000357 A EEP200000357 A EE P200000357A EE 200000357 A EE200000357 A EE 200000357A
Authority
EE
Estonia
Prior art keywords
azasteroids
aryloxy
intermediates
preparation
Prior art date
Application number
EEP200000357A
Other languages
English (en)
Inventor
R. Humphrey Guy
A. Miller Ross
Li Wenjie
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE200000357A publication Critical patent/EE200000357A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • C07C59/205—Saturated compounds having only one carboxyl group and containing keto groups containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EEP200000357A 1997-12-23 1998-12-18 Meetod 16ß-arüüloksü-4-asasteroidide valmistamiseks ning vaheühendid EE200000357A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6853697P 1997-12-23 1997-12-23
PCT/US1998/027136 WO1999032507A2 (en) 1997-12-23 1998-12-18 Intermediates and process for the synthesis of 17-unsubstituted 16.beta.-aryloxy 4-azasteroids

Publications (1)

Publication Number Publication Date
EE200000357A true EE200000357A (et) 2001-12-17

Family

ID=22083194

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000357A EE200000357A (et) 1997-12-23 1998-12-18 Meetod 16ß-arüüloksü-4-asasteroidide valmistamiseks ning vaheühendid

Country Status (10)

Country Link
US (1) US6187925B1 (et)
EP (1) EP1042356A2 (et)
AR (1) AR014944A1 (et)
AU (1) AU2306799A (et)
EA (1) EA002333B1 (et)
EE (1) EE200000357A (et)
IS (1) IS5507A (et)
TR (1) TR200001969T2 (et)
TW (1) TW548276B (et)
WO (1) WO1999032507A2 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016257A1 (es) * 1998-05-14 2001-06-20 Merck & Co Inc Proceso para la sintesis estereoselectiva de ariloxi-4-aza-5alfa-androstan-3-onas, 16 alfa y 16 beta-sustituidas e insustituidas, e intermediariosobtenidos en dicho proceso.
NO20031736D0 (no) * 2003-04-15 2003-04-15 Amersham Health As Forbindelser

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2759952A (en) 1955-08-01 1956-08-21 Lasdon Foundation Inc Cyclopentano-phenanthrene compounds
GB813845A (en) 1955-08-01 1959-05-27 Lasdon Foundation Inc Improvements in cyclopentanophenanthrene compounds
US4377584A (en) 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4760071A (en) 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
DE69012558T2 (de) 1989-05-30 1995-02-23 Upjohn Co Oxidative herstellung von a-nor-17-beta-carboxy-3,5-seco-androstan-5-on-3-säure.
US5021575A (en) 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
US5120847A (en) 1990-08-27 1992-06-09 Merck & Co., Inc. Process for iodinating or brominating the α-methylenic carbon of a secondary amide
US5091534A (en) 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
US5237064A (en) 1992-05-20 1993-08-17 Merck & Co., Inc. Process for producing 7β-substituted-aza-5αandrostan-3-ones
NZ275293A (en) 1993-10-21 1998-02-26 Merck & Co Inc 16-substituted-4-aza-androstanes for use as 5-alpha-reductase isozyme 1 inhibitors
KR970703359A (ko) 1994-05-19 1997-07-03 위노쿠르 멜빈 알릴 그룹을 갖는 스테로이드의 산화(Oxidation of steroids having allylic groups)
US5470976A (en) 1994-09-07 1995-11-28 Merck & Co., Inc. Process for the stereoselective reduction of steroid enelactams
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
ES2178750T3 (es) 1996-02-14 2003-01-01 Aventis Pharma Inc 17-beta- iclopropil(amino/oxi)4-aza esteroides como inhibidores activos de la 5-alfa-reductasa y de c17-20-liasa de testosterona.

Also Published As

Publication number Publication date
US6187925B1 (en) 2001-02-13
WO1999032507A3 (en) 1999-09-10
AU2306799A (en) 1999-07-12
TR200001969T2 (tr) 2000-12-21
WO1999032507A2 (en) 1999-07-01
EA002333B1 (ru) 2002-04-25
AR014944A1 (es) 2001-04-11
IS5507A (is) 2000-05-23
EP1042356A2 (en) 2000-10-11
EA200000705A1 (ru) 2000-12-25
TW548276B (en) 2003-08-21

Similar Documents

Publication Publication Date Title
NO990756D0 (no) FremgangsmÕte for fremstilling av mellomprodukter for florfenikol
HUP0004388A3 (en) Process for the preparation of oxazolidinones, intermediates and preparation thereof
IL113850A0 (en) Process and intermediates for the preparation of 3-aryluracils
NO991382D0 (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
HUP0003958A3 (en) Process for preparation of 4-aryl-piperidines and intermediates
HUP0004855A3 (en) Method for the synthesis of quinoline derivatives and intermediates
HUP9600320A3 (en) Process and new intermediates for the preparation of triazolinon-derivatives
CY2005003I2 (el) Mεθοδοι και ενδιαμεσα χρησιμα για κατασκευη αντιφολικων
HUP0104278A3 (en) Novel process for the preparation of 7-azaindolyl-3-carboxylic acid and 7-azaindol and their intermediates
EE200000055A (et) Protsess tsüklopropüülatsetüleeni valmistamiseks
DE69922440D1 (de) Verfahren und Zwischenprodukte zur Herstellung von 2,3-Pyridindicarboxylatderivaten
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
FI956058A0 (fi) Menetelmä glutaaridialdehydin valmistamiseksi
HUP9903751A3 (en) Intermediates for the preparation of 2-imidazoline-5-ones
DE69804920D1 (de) Verfahren zur Herstellung von Furopyridin-Derivaten und Zwischenprodukten
EE200100333A (et) Meetod 2-halo-3-nitro-4-aminopüridiini valmistamiseks ja selleks vajalike vaheühendite saamine
DE69819093D1 (de) Apparat zur Herstellung von Metalbändern
DE69840863D1 (de) Verfahren zur Herstellung von 2,6-Diaminopurin-2'deoxyribosid und 2'-Deoxyguanosin
DE59510416D1 (de) Verfahren zur Herstellung von Chlormethylpyridin Derivaten und Acylaminomethylpyridine als Zwischenprodukte
NO990185L (no) FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter
AU4708697A (en) Process for the preparation of eberconazol and intermediates thereof
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
DE69510390D1 (de) Verfahren zur Herstellung von Allylchinon-Derivaten und Zwischenprodukte